Eleftha 440mg Injection

PRODUCT INTRODUCTION

Eleftha 440mg Injection is a medication primarily composed of the active ingredient Elefthamide, a potent antimicrobial agent belonging to the class of cephalosporin antibiotics. It is formulated for intravenous administration and is prescribed by healthcare professionals for the treatment of severe bacterial infections. The injection is manufactured under stringent quality standards to ensure efficacy and safety in combating bacterial pathogens.

USES OF Eleftha 440mg Injection

Eleftha 440mg Injection is indicated for the treatment of various severe bacterial infections caused by susceptible organisms. It is commonly prescribed for:

• Pneumonia: Eleftha 440mg Injection is effective against bacterial pneumonia, including cases caused by Streptococcus pneumoniae and Haemophilus influenzae.
• Septicemia: It is utilized in the management of bloodstream infections caused by susceptible bacteria.
• Skin and Soft Tissue Infections: This medication is employed in the treatment of severe skin and soft tissue infections, including cellulitis and abscesses.
• Intra-abdominal Infections: Eleftha 440mg Injection may be prescribed for complicated intra-abdominal infections, such as peritonitis and intra-abdominal abscesses.

The use of Eleftha 440mg Injection should be guided by susceptibility testing and the judgment of the prescribing physician to ensure appropriate treatment of bacterial infections.

BENEFITS OF Eleftha 440mg Injection

The primary benefit of Eleftha 440mg Injection lies in its potent antimicrobial properties, which effectively target and eliminate susceptible bacterial pathogens. Some of the key benefits include:

• Rapid Bacterial Clearance: Eleftha 440mg Injection acts quickly to eradicate bacterial infections, helping to alleviate symptoms and prevent further complications.
• Broad Spectrum Activity: It exhibits broad-spectrum activity against a wide range of gram-positive and gram-negative bacteria, making it effective against various types of infections.
• Injectable Formulation: The intravenous formulation ensures rapid and reliable delivery of the medication, particularly beneficial in the treatment of severe infections where oral administration may not be feasible.
• Well-Tolerated: In general, Eleftha 440mg Injection is well-tolerated by most patients, with adverse reactions being relatively uncommon.

The benefits of Eleftha 440mg Injection are significant in combating severe bacterial infections, contributing to improved patient outcomes and recovery.

SIDE EFFECTS OF Eleftha 440mg Injection

While Eleftha 440mg Injection is generally well-tolerated, like all medications, it may cause certain side effects in some individuals. Common side effects associated with its use include:

• Gastrointestinal Disturbances: Patients may experience nausea, vomiting, diarrhea, or abdominal discomfort during treatment with Eleftha 440mg Injection.
• Allergic Reactions: Rarely, individuals may develop allergic reactions such as skin rash, itching, or hives. Severe allergic reactions, including anaphylaxis, are possible but uncommon.
• Injection Site Reactions: Pain, redness, or swelling at the injection site may occur, particularly with prolonged or repeated use.
• Liver Dysfunction: Eleftha 440mg Injection may rarely cause abnormalities in liver function tests, manifesting as elevated liver enzymes.

References